SOURCE: Cypress Bioscience, Inc.

April 11, 2007 06:30 ET

Cypress Bioscience, Inc. to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference

SAN DIEGO, CA -- (MARKET WIRE) -- April 11, 2007 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference on Thursday, April 12, 2007.

The CIBC conference is being held at the Millennium Broadway Hotel, New York, NY. Ms. Johnson is scheduled to present on Thursday, April 12th at 9:45 a.m. Eastern Time.

Investors, analysts and the general public are invited to listen to a live audio broadcast of this presentation over the Internet. The broadcast can be accessed at http://www.veracast.com/webcasts/cibcwm/biotech07/37204149.cfm.

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/news/events.php.

About Cypress Bioscience, Inc.

Cypress is committed to be the innovator and leader in providing products that improve the treatment of Functional Somatic Syndromes and other central nervous system conditions. Cypress' strategy involves acquiring/in-licensing undervalued central nervous system active compounds and developing them for new indications.

For more information about Cypress, please visit the Company's web site at www.cypressbio.com.

Contact Information

  • For additional information please contact:
    Cypress Bioscience
    Sabrina Martucci Johnson
    Executive VP, Chief Business Officer and Chief Financial Officer
    Mary Gieson
    Investor Relations
    (858) 452-2323